What's at stake: Ebos had been in a trading halt since last Thursday following speculation it was eyeing the acquisition of pets and vets business Greencross.
Background: Private equity firm TPG took Greencross private in 2019 at A$5.55 a share and later sold a 45% stake to AustralianSuper and The Healthcare of Ontario Pension Plan in early 2022 in a deal that valued that company at more than A$3.5 billion.
Main players: Ebos, Greencross, AustralianSuper, The Healthcare of Ontario Pension Plan, Matt Goodson, Greg Smith, NZX.
The last-minute collapse of a potential multi-billion-dollar acquisition by dual-listed healthcare product company Ebos has been labelled “disappointing” and a “real shame” for New Zealand’s capital market.
Last Thursday, Ebos went into a trading halt after the Australian Financial
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Key points
What's at stake: Ebos had been in a trading halt since last Thursday following speculation it was eyeing the acquisition of pets and vets business Greencross.
Background: Private equity firm TPG took Greencross private in 2019 at A$5.55 a share and later sold a 45% stake to AustralianSuper and The Healthcare of Ontario Pension Plan in early 2022 in a deal that valued that company at more than A$3.5 billion.
Main players: Ebos, Greencross, AustralianSuper, The Healthcare of Ontario Pension Plan, Matt Goodson, Greg Smith, NZX.
